Third, some data recommended by the AHA for defining CKM stages 3–4 such as cardiac biomarkers, cardiac computed tomography, atrial fibrillation, coronary angiography, and peripheral artery disease, were not available in the NHANES database, which may have led to an underestimation of stages 3 and 4. The gene discussed is CKM; the disease is peripheral arterial disease.